Kilian Kelly, Chief Executive Officer & Managing Director at Cynata Therapeutics Limited, holds 619.65K shares in Cynata Therapeutics Limited (Ticker: CYYNF). Most recently, Kilian Kelly Bought $94,143 shares of Cynata Therapeutics Limited on Nov 22, 2023 for an estimated value of 12.44K.
What is the percentage of profitable transactions made by Kilian Kelly?
The percentage of profitable transactions made by Kilian Kelly is ―.
What is the average return per transaction made by Kilian Kelly?
The average return per transaction made by Kilian Kelly is ―.
What stocks does Kilian Kelly hold?
Kilian Kelly holds: CYYNF stocks.
What was Kilian Kelly’s latest transaction?
Kilian Kelly latest transaction was an Informative Buy of $12.44K.
What was Kilian Kelly's most profitable transaction?
Kilian Kelly’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
What is Kilian Kelly's role in Cynata Therapeutics Limited?
Kilian Kelly's role in Cynata Therapeutics Limited is Chief Executive Officer & Managing Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.